Author:
Ho Cheryl,Siegfried Jennifer,Remo Karen,Laskin Janessa
Funder
Boehringer Ingelheim, Eli Lilly and Roche
The Eleni Skalbania Endowment fund for Lung Cancer Research and the BC Cancer Foundation
Subject
Cancer Research,Pulmonary and Respiratory Medicine,Oncology
Reference23 articles.
1. Vinorelbine plus cisplatin vs. observation in resected non-small-cell lung cancer;Winton;N. Engl. J. Med.,2005
2. Adjuvant vinorelbine plus cisplatin versus observation in patients with completely resected stage IB-IIIA non-small-cell lung cancer (adjuvant navelbine international trialist association [ANITA]): a randomised controlled trial;Douillard;Lancet Oncol.,2006
3. Lung adjuvant cisplatin evaluation: a pooled analysis by the LACE collaborative group;Pignon;J. Clin. Oncol.,2008
4. Follow-up and surveillance of the patient with lung cancer after curative-intent therapy: diagnosis and management of lung cancer, 3rd ed: American college of chest physicians evidence-based clinical practice guidelines;Colt;Chest,2013
5. Y.C. Ung, L.H. Souter, G. Darling, J. Dobranowski, L. Donohue, N. Leighl, et al., Follow-up and surveillance of curatively treated lung cancer patients. Toronto (ON): Cancer Care Ontario program in evidence-based care evidence-based series no.: 26-3., 2014 Aug 29 update. http://www.cancercare.on.ca/.
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献